Zevra Therapeutics, Inc. ZVRA Gross Profit

Gross Profit at other companies

BioMarin PharmaceuticalsBMRN

$786.91M+16.5%

RFL

Rafael Holdings, Inc.RFL

$131K-56.3%

Rigel PharmaceuticalsRIGL

$54.21M+10.8%

Eton Pharmaceuticals, Inc.ETON

$14.74M+49.4%

ANI PharmaceuticalsANIP

$165.89M+21.3%

LQD

Liquidia CorporationLQDA

$1.6M+6.5%

FAQ

What is Zevra Therapeutics, Inc.'s gross profit?

Zevra Therapeutics, Inc. (ZVRA) reported gross profit of $38.14M in Q2 2026.

How has Zevra Therapeutics, Inc.'s gross profit changed year-over-year?

Zevra Therapeutics, Inc.'s gross profit increased by 182.5% year-over-year, from $13.5M to $38.14M.

What is the long-term trend for Zevra Therapeutics, Inc.'s gross profit?

Over 4 years (2021 to 2025), Zevra Therapeutics, Inc.'s gross profit has grown at a 35.6% compound annual growth rate (CAGR), from $26.59M to $89.99M.

What does gross profit mean?

Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.